Consumer Healthcare

Sensodyne-Maker Haleon Posts Unexpected Drop In Revenue On Weak Demand For Its Painkiller

Haleon posted an unexpected drop in third-quarter revenue, hurt by a weak demand for its painkiller in Australia and the Middle East.

Haleon Forecasts High Single-Digit Growth For Annual Organic Operating Profit

Haleon has forecast high single-digit growth in organic operating profit in 2024, after reporting a 4% rise in half-year pre-tax earnings amid strong deman...

GSK Raises £1.25bn From Offloading Haleon Stake At A Discount

GSK has raised £1.25 billion (€1.46 billion). from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker...

Sensodyne-Maker Haleon To Shut UK Manufacturing Site, With More Than 400 Jobs Hit

Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reut...

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon To 24%

Consumer healthcare firm Haleon has said that U.S. drugmaker Pfizer, its top shareholder, will sell down its stake in the company to about 24%.

Haleon Reports Sluggish First-Quarter Growth

Despite price increases, Haleon's roster of products has largely kept cheaper private-label competition at bay, although the cost-of-living squeeze and com...

Unilever Investor Lindsell Train Says Changes Mark Fresh Approach

Unilever top-10 investor Lindsell Train welcomed its recent management changes and said it had already discussed the consumer goods company's next ste...

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...